Laredo Health Department hosts FREE At-Home COVID-19 Tests

Community NewsNews
396

Translate to Spanish or other 102 languages!

The City of Laredo Health Department will host its first-ever pop-up to give free at-home COVID-19 tests to the community. The Laredo Health Department will be at the intersection of Guadalupe and Meadow giving out free at-home COVID-19 tests – acquired by Gateway Community Health Center. Image for illustration purposes
The City of Laredo Health Department will host its first-ever pop-up to give free at-home COVID-19 tests to the community. The Laredo Health Department will be at the intersection of Guadalupe and Meadow giving out free at-home COVID-19 tests – acquired by Gateway Community Health Center. Image for illustration purposes

Mega Doctor News

- Advertisement -

LAREDO, Texas— The City of Laredo Health Department will host its first-ever pop-up to give free at-home COVID-19 tests to the community. The Laredo Health Department will be at the intersection of Guadalupe and Meadow giving out free at-home COVID-19 tests – acquired by Gateway Community Health Center.

WHO:            City of Laredo Health Department

WHAT:          FREE at-home COVID-19 Tests

- Advertisement -

WHEN:          Saturday, July 9, 2022, from 9:00 – 11:00 AM

WHERE:        Intersection of Guadalupe and Meadow

- Advertisement -
- Advertisement -

Latest news

- Advertisement -
Previous article
Leading physician organizations issue COVID-19 kids vaccinations letter
Next article
DHR Health Clinics Welcomes Dr. Henry Herrera to DHR Health Gastroenterology Institute

More Articles

Study: Supplement Plus Chemo Boosts Pancreatic Cancer Survival

L-glutamine, an amino acid that occurs naturally in the body and plays an important role in digestion, has been studied as a potential way to ease side effects in other cancers.

How Artificial Intelligence Is Improving Prostate Cancer Diagnostics

Mega Doctor News CLEVELAND CLINIC - September is Prostate Cancer Awareness Month.  Prostate cancer is...

FDA Approves First Drug of Its Kind for Polycythemia Vera, a Rare Blood Disorder

The U.S. Food and Drug Administration today approved Mimrylo (rusfertide), a new treatment for adults with polycythemia vera, a rare blood disorder that causes the body to make too many red blood cells.

FDA Approves First Oral Drug Indicated to Treat Dermatomyositis in Adults

Lisraya is the first FDA-approved oral treatment option for patients with dermatomyositis, addressing the high unmet need for this rare disease.
- Advertisement -